Key Takeaways
- All value, no volume in FY23: Consolidated income rose 31% and profit surged 68%, but the entire top-line expansion came from improved realizations, not volume growth, in both chromium and barium chemicals.
- Margins expanded on cost control, not pricing power: Consolidated EBITDA margin reached 18.9% in Q4 and ~17% for the full year, driven by lower logistics and employee costs; management wants to hold 18% through FY24.
- Barium sulphate is the near-term catalyst: The 30,000-ton precipitated barium sulphate project enters commercial production in July, making Vishnu India's only producer and the largest barium chemicals player domestically.
- Prices have bottomed, management says: Realizations corrected through H2 FY23 as freight costs fell; management sees no further price correction ahead and expects FY24 growth to come from volumes.
- What to watch next quarter: Whether barium sulphate commercial production starts on schedule in July, the pace of customer approvals for specialty grades, and any sign that chromium volumes are actually picking up after a year of stagnation.
The FY23 Story: Value Growth Masking Flat Volumes
- Top-line growth was all price, not volume: Both chromium and barium chemicals delivered higher revenue entirely through improved realizations; chromium value grew more than 30% YoY, while barium realization rose nearly 8% YoY with no major volume growth.
- Chromium pricing corrected through the year: Prices started coming down from Q2 onwards as freight costs fell, and those reductions were passed to customers; despite the price decline from mid-Q2 through Q4, no volume degrowth was seen.
- Barium demand was disrupted by European gas prices: In Q2 and Q3, natural gas price spikes in Europe hit barium product uptake because customers, not Vishnu, are located there; demand is now returning as gas prices have fallen to pre-COVID levels.
- Q4 revenue did not jump sequentially: A price correction across the chemical industry on account of raw material and freight reductions kept Q4 revenue flat versus Q3; management characterizes this as a price correction, not a price drop.
- Inventory discipline was tight: Barium chemicals sold 99% of production through the year, carrying no inventory as of March 31; chromium inventory is entirely placed against orders for delivery over time.
Siddartha Cherukuri: "We have already seen some price adjustments and we are not seeing the prices correcting any further and whatever raw material price adjustments and the freight adjustments we have passed it on and the way we look at it the prices have adjusted and have already bottomed."
Margin Walk: Cost Leverage, Not Pricing Power
- Chromium EBITDA margin jumped 350 bps YoY: Standalone chromium EBITDA margin rose from ~14.5% in FY22 to 18% in FY23, driven entirely by cost-side improvements: conversion cost fell 1% of revenues, employee cost dropped from 3.5% to 2.9%, and selling and administrative cost fell from 12.3% to 10.5%.
- Chromium gross margins were flat: Gross margins moved only from ~43% to ~44% YoY because key raw material prices remained high through FY23 versus FY22, so blended realization did not decline materially.
- Barium broke even at PAT despite higher revenue: Q4 FY23 barium revenue was ₹37–38 Crores versus ₹28 Crores last year, but the segment still broke even at PAT level because finance cost was ~₹2.8 Crores in Q4 alone, out of ₹6.6 Crores for the full year, dragging down PBT.
- Consolidated EBITDA margin target is 18%: Q4 FY23 delivered 18.9% and management wants to maintain at least 18% through FY24; the full-year FY23 consolidated EBITDA margin was about 17%.
- Backward integration is the next margin lever: Soda ash recovery increases proportionately as chromium production rises, and the process also negates sulfuric acid as a raw material; enough spare capacity exists in CO2 gas and process equipment to handle additional soda ash generation.
Hanumant Bhansali: "The pricing is determined based on three factors, factor number one is raw material cost, factor number two is the freight cost, factor number three is the overall demand and supply or the market sentiments as we call it... the overall endeavor will be to work on a certain EBITDA and maintain that EBITDA going forward."
Barium Sulphate: The FY24 Catalyst
- Commercial production starts in July: The 30,000-ton precipitated barium sulphate capacity addition is expected to commence commercial production in July 2023, with full revenue numbers visible from Q3 FY24.
- First-mover position in India: Upon commissioning, Vishnu becomes the largest producer of barium chemicals in India and the only domestic producer of precipitated barium sulphate, giving it a first-mover advantage to tap customers currently relying on imports.
- Demand visibility is strong: Management cites consistent 12% YoY growth in the Indian powder coating industry, the primary end-market, with production rising from 67,000 tons four years ago to 140,000 tons today; good demand also exists in North America and Europe, where existing distribution channels are showing interest.
- Specialty grade commands a premium: The product range spans ₹50 per kilo for commodity grades to ₹100 per kilo for specialty grades; management is focused on the specialty end and is currently in the sampling phase, waiting for customer approvals that will probably take one or two months.
- First-year utilization target is 50%+: Management expects upwards of 50% utilization in the first year, contingent on receiving product approvals from end users sooner rather than later.
- Quality positioning versus China: Management believes it can prove technical benefits in consumption and gloss effect versus Chinese supply in India, though it acknowledges this will take time to establish.
Siddartha Cherukuri: "What is more interesting is there has been a consistent growth of 12% on a Y-on-Y basis because it is directly related to the powder coating industry. If you go back four years ago, the powder coating production in India was about 67,000 tons today, it stands at 1,40,000 tons."
Volume Growth Returns in FY24
- FY23 was a year of zero volume growth: Both chromium and barium chemicals saw no volume expansion; all growth came from value. Management states that after a gap of one entire year, volume growth is coming back.
- Barium volumes are already picking up: Q4 was the second-best quarter for barium volume offtake in FY23, and volumes have been improving from January onwards; management expects gradual improvement going forward.
- Barium carbonate utilization target is 70%+: Installed capacity is 60,000 tons and utilization was only 55–60% in FY23 because of the European gas price disruption; the FY24 target is upwards of 70% through the year.
- Chromium gets a 10,000-ton capacity boost: The additional capacity was already added, and with no major maintenance shutdown planned in FY24, the full effect will be realized in the current financial year; overall utilization was more than 85% excluding the Q3 maintenance quarter.
- Product mix will drive chromium volumes: Management will focus more on chromic acid, where there is good traction from wood preservative and plating applications, and chrome oxide, which eventually leads to chrome metal production; both carry better gross margins and better overall realization.
- China is not a chromium competitor: In standalone chromium chemicals, competing players are the US, Turkey, and South Africa; whatever chromium chemicals China produces are sold domestically. In barium, China is an important player but no significant price pressure or volume decrease is currently visible.
Hanumant Bhansali: "From our point of view, we are looking at driving more volumes than trying to look at a particular realization per kg, because that automatically takes care of my desired EBITDA and desired gross profits."
The Longer Game: Chromium Metal and Barium Specialties
- Chromium metal R&D is in advanced stages: Management is working on producing chromium metal for the SuperAlloy industry and welding electrodes, targeting an import-substitution opportunity in India's growing defense sector; there is currently no domestic producer.
- Pilot plant targeted for end of 2023: The R&D activity is very advanced, and management hopes to start looking at a pilot plant somewhere towards the end of this year; the barium sulphate project takes near-term priority.
- High-purity barium carbonate is another vector: Management is working on value-added barium products, including high-purity barium carbonate used in the semiconductor industry, with good growth prospects in Korea, Japan, and the US.
- No production cuts seen globally in chromium: Management has not witnessed or heard of any production cuts; prices have already adjusted and no further price adjustment is expected.
Siddartha Cherukuri: "Currently, we are more focused towards completing our barium sulphate project because we are expecting the commercial production to commence in the month of July and chromium metal... we are hoping to start looking at a pilot plant somewhere towards end of this year."
Balance Sheet & Capital Allocation
- ₹40 Crores of debt reduction planned in FY24: Nearly about ₹40 Crores of debt will be reduced during the financial year.
- Working capital is tightening: Management expects a further drop in inventory days through the year; payable days are expected to remain in the 84–95 day range for the next couple of quarters, with a target to close the year around 70 to 75 days.
- QIP approvals are in place: Board approvals for a QIP and an enabling approval have been received; the enabling approval is valid for 12 months, and no further update was provided as of the call.
- Dividend declared: The board recommended a dividend of ₹0.4 per equity share of ₹2 face value for FY2023, subject to shareholder approval at the AGM.
- Barium carbonate project is fully capitalized: The 20,000-ton barium carbonate project was fully capitalized on the balance sheet as of March 31, 2022, and is fully completed.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Precipitated barium sulphate commercial production | 30,000-ton capacity to commence production | July 2023 |
| Barium sulphate revenue visibility | Full numbers visible | Q3 FY24 |
| Barium carbonate capacity utilization | Upwards of 70% | Through FY24 |
| Barium sulphate first-year utilization | Upwards of 50% | First year of operation |
| Consolidated EBITDA margin | Maintain 18% or higher | Through FY24 |
| Debt reduction | Nearly ₹40 Crores | During FY24 |
| Payable days | Close the year around 70–75 days | FY24 exit |
| Chromium metal pilot plant | Start looking at a pilot plant | Towards end of 2023 |
Key Metrics
| Metric | Q4 FY23 |
|---|---|
| Consolidated revenue | ₹339 Cr, up 1% YoY and 2% QoQ |
| Consolidated EBITDA | ₹64 Cr, up 20% YoY and 10% QoQ |
| Consolidated EBITDA margin | 18.9%, vs 15.8% in Q4 FY22 |
| Consolidated PAT | ₹36 Cr, up 25% YoY and 12% QoQ |
| Net profit margin | 10.5%, vs 8.5% in Q4 FY22 |
| Consolidated total income (FY23) | ₹1,406 Cr, growth of 31% YoY |
| Consolidated EBITDA margin (FY23) | 17.4%, vs 15% in FY22, increase of 200 bps YoY |
| Consolidated PAT (FY23) | ₹137 Cr, vs ₹81 Cr in FY22, increase of 68% YoY |
| PAT margin (FY23) | 9.7%, vs 7.6% in FY22 |
| ROCE | Over 35%, vs 28% YoY |
| Debt to equity ratio | 0.9x, vs 1.3x a year ago |
| Dividend per share | ₹0.4 per equity share of ₹2 face value for FY23 |
| Domestic sales growth (FY23) | 36% YoY |
| Export sales growth (FY23) | 26% YoY |
| Barium chemicals capacity utilization (FY23) | 55–60% of 60,000 tons installed capacity of barium carbonate |
| Chromium chemicals capacity utilization (FY23) | More than 80%, crossed 90% in certain quarters, barring Q3 maintenance |
| Barium chemicals realization growth (FY23) | Nearly 8% YoY |
| Chromium chemicals value growth (FY23) | More than 30% YoY |
| Chromium chemicals EBITDA margin (FY23) | 18%, vs 14.5% in FY22 |
| Vishnu Barium Q4 FY23 EBITDA margin | About 11%, vs 9.5% in Q4 FY22 |
| CWIP as of 31st March 2023 | ₹98 Cr, ₹93 Cr for precipitated barium sulphate project, ₹5 Cr for chromium replacement capex |
| Barium chemicals installed capacity upon commissioning | 90,000 tons, comprising 60,000 tons barium carbonate and 30,000 tons precipitated barium sulphate |
| Expected revenue from barium sulphate and sodium sulfide product mix | Upwards of ₹250 Cr |
| Expected barium sulphate utilization in first year | Upwards of 50% |
| Barium carbonate utilization target for FY24 | Upwards of 70% through the year |
| Consolidated inventory days (FY23) | About 91 days, reduced from 112 days in FY22 |
| Debt reduction planned for FY24 | Nearly ₹40 Cr |
| Pending capex for FY24 | Nearly ₹10 Cr |